| Description |
1 online resource (vii, 208 pages) : illustrations |
| Series |
Cambridge studies in society and the life sciences |
|
Cambridge studies in society and the life sciences.
|
| Contents |
Cover; Half-title; Series-title; Title; Copyright; Contents; Figures; Acknowledgements; 1 Personalised medicine -- A revolution in healthcare; 2 Pharmacogenetics, expectation and promissory science; 3 Genetics, moral risk and professional resistance; 4 Clinical resistance to Alzheimer's pharmacogenetics; 5 Research, industry and pharmacogenetic literacy; 6 Engineering the clinic -- getting personalised medicine into practice; 7 The fourth hurdle -- cost-effectiveness and the funding of pharmacogenetics; 8 Disappointment and disclosure in the pharmacogenetic clinic |
| Summary |
Applies a social science perspective to exploring issues arising in clinical practice as a result of drug development linked to genetic testing. These include the social context within which new drugs are trialled, attitudes of the clinicians asked to administer them, expectations of clinicians and patients and associated ethical issues |
| Bibliography |
Includes bibliographical references (pages 182-204) and index |
| Notes |
Print version record |
| Subject |
Pharmacogenetics -- Social aspects
|
|
Pharmacology -- Social aspects
|
|
Social ecology.
|
|
Social Environment
|
|
human ecology.
|
|
Social ecology
|
| Form |
Electronic book
|
| LC no. |
2004047383 |
| ISBN |
0511224915 |
|
9780511224911 |
|
0511225563 |
|
9780511225567 |
|
9780511224249 |
|
0511224249 |
|
9780521841771 |
|
0521841771 |
|
9780521602655 |
|
0521602653 |
|
